AMP Final Rule, 340B Drug Discount Program to Be Discussed at Government Pricing Conference

Chicago, IL, March 23, 2016 (Newswire.com) - Legal experts and pharmaceutical professionals are invited to discuss the most pressing regulatory affairs facing the industry at the Pharmaceutical Government Pricing & Contracting Conference. Hosted by Q1 Productions, this conference will be held June 6-7, 2016 in Arlington, VA.

This two-day event will feature presentations, case studies, and panel discussions on topics ranging from the 340B Drug Discount Program to implementing AMP final rule in regards to the direction of bundling. Representatives from Sidley Austin LLP, Arnold & Porter, and Hogan Lovells will offer legal perspective in addition to insights from pharmaceutical companies like Amgen and Celgene.

Representatives from Sidley Austin LLP, Arnold & Porter, and Hogan Lovells will offer legal perspective in addition to insights from pharmaceutical companies like Amgen and Celgene.

Delegates will have the opportunity to network and discuss the unique challenges facing them following the implementation of the AMP final rule. In addition to presentations by experts, there will be panel discussions to allow delegates to voice their concerns and insights and hear cross-industry perspective.

For more information on the Pharmaceutical Government Pricing & Contracting Conference, please visit www.q1productions.com/pharma-gov-pricing or email [email protected]. You can also follow the conference on Twitter @Q1productions, #Q1GovPricing.

About the Organizer

Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.